Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.

25-hydroxycholesterol cholesterol-25-hydroxylase inflammatory bowel disease intestinal immunity mechanism

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 16 06 2023
accepted: 21 08 2023
medline: 19 9 2023
pubmed: 18 9 2023
entrez: 18 9 2023
Statut: epublish

Résumé

Inflammatory bowel disease (IBD), a general term encompassing Crohn's disease (CD) and ulcerative colitis (UC), and other conditions, is a chronic and relapsing autoimmune disease that can occur in any part of the digestive tract. While the cause of IBD remains unclear, it is acknowledged that the disease has much to do with the dysregulation of intestinal immunity. In the intestinal immune regulatory system, Cholesterol-25-hydroxylase (CH25H) plays an important role in regulating the function of immune cells and lipid metabolism through catalyzing the oxidation of cholesterol into 25-hydroxycholesterol (25-HC). Specifically, CH25H focuses its mechanism of regulating the inflammatory response, signal transduction and cell migration on various types of immune cells by binding to relevant receptors, and the mechanism of regulating lipid metabolism and immune cell function via the transcription factor Sterol Regulator-Binding Protein. Based on this foundation, this article will review the function of CH25H in intestinal immunity, aiming to provide evidence for supporting the discovery of early diagnostic and treatment targets for IBD.

Identifiants

pubmed: 37720208
doi: 10.3389/fimmu.2023.1241262
pmc: PMC10500599
doi:

Substances chimiques

cholesterol 25-hydroxylase EC 1.14.99.38

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1241262

Informations de copyright

Copyright © 2023 Zhong, He, Wang, Lin and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Microbiol Biotechnol. 2022 Jul 28;32(7):825-834
pubmed: 35791076
Immunity. 2013 Jan 24;38(1):106-18
pubmed: 23273843
J Clin Invest. 2009 Sep;119(9):2441-50
pubmed: 19729841
J Clin Invest. 2012 Jan;122(1):337-47
pubmed: 22156197
Elife. 2015 Jul 14;4:e08009
pubmed: 26173179
J Lipid Res. 2009 Nov;50(11):2258-64
pubmed: 19502589
Atherosclerosis. 2014 Dec;237(2):443-52
pubmed: 25463072
Cell. 2017 Nov 16;171(5):1057-1071.e11
pubmed: 29033131
PLoS One. 2017 Sep 19;12(9):e0184985
pubmed: 28926619
Nat Genet. 2023 May;55(5):796-806
pubmed: 37156999
Annu Rev Biochem. 2003;72:137-74
pubmed: 12543708
Gut Microbes. 2021 Jan-Dec;13(1):1968257
pubmed: 34494943
Nat Med. 2021 Nov;27(11):1970-1981
pubmed: 34675383
Immunol Rev. 2010 Nov;238(1):247-62
pubmed: 20969597
Clin Exp Immunol. 1997 Oct;110(1):104-13
pubmed: 9353156
Science. 2015 Nov 20;350(6263):981-5
pubmed: 26472762
J Clin Invest. 2008 Jun;118(6):2269-80
pubmed: 18497880
J Innate Immun. 2011;3(6):550-64
pubmed: 22025201
Cell Mol Gastroenterol Hepatol. 2021;12(1):321-333
pubmed: 33689803
Cell Biol Toxicol. 2009 Apr;25(2):127-39
pubmed: 18317936
ACS Biomater Sci Eng. 2021 Nov 8;7(11):5255-5268
pubmed: 34643375
Mucosal Immunol. 2014 Nov;7(6):1416-28
pubmed: 24803164
Nat Chem Biol. 2015 Feb;11(2):141-7
pubmed: 25558972
J Leukoc Biol. 2010 Dec;88(6):1081-7
pubmed: 20699362
Front Pharmacol. 2021 Aug 18;12:704112
pubmed: 34483906
Metabolites. 2020 Sep 28;10(10):
pubmed: 32998240
Cell Metab. 2015 Feb 03;21(2):286-298
pubmed: 25651181
J Lipid Res. 2022 Feb;63(2):100165
pubmed: 34953867
Immunity. 2020 Mar 17;52(3):452-463
pubmed: 32187516
Immunol Rev. 2013 Mar;252(1):104-15
pubmed: 23405898
J Cell Mol Med. 2018 Nov;22(11):5494-5503
pubmed: 30091835
Gastroenterology. 2007 Dec;133(6):1882-92
pubmed: 18054560
Front Immunol. 2020 Nov 16;11:554880
pubmed: 33329513
Sci Rep. 2020 Aug 28;10(1):14246
pubmed: 32859970
Nat Immunol. 2005 May;6(5):507-14
pubmed: 15821737
EMBO J. 2020 Nov 2;39(21):e106057
pubmed: 32944968
Nature. 2007 Jul 26;448(7152):427-34
pubmed: 17653185
Elife. 2014 Jun 11;3:
pubmed: 24920391
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16764-9
pubmed: 19805370
Immunity. 2021 Oct 12;54(10):2273-2287.e6
pubmed: 34644558
Braz J Med Biol Res. 2008 Jul;41(7):545-56
pubmed: 18719735
Eur J Clin Invest. 2002 Jan;32(1):35-42
pubmed: 11851725
Nat Commun. 2016 Oct 12;7:13130
pubmed: 27731330
Clin J Gastroenterol. 2018 Feb;11(1):1-10
pubmed: 29285689
J Autoimmun. 2018 Nov;94:122-133
pubmed: 30098863
Viruses. 2020 Jul 06;12(7):
pubmed: 32640529
J Lipid Res. 2018 Mar;59(3):439-451
pubmed: 29298812
Immunopharmacol Immunotoxicol. 2020 Oct;42(5):385-391
pubmed: 32619377
Semin Immunol. 2015 May;27(3):177-83
pubmed: 25818531
J Immunol. 2008 Mar 1;180(5):3305-12
pubmed: 18292555
Nat Immunol. 2023 Mar;24(3):531-544
pubmed: 36658240
J Virol. 2018 Aug 29;92(18):
pubmed: 29950420
Mol Endocrinol. 2010 May;24(5):923-9
pubmed: 20203100
J Clin Invest. 2021 May 17;131(10):
pubmed: 33998600
Mol Nutr Food Res. 2007 Sep;51(9):1102-6
pubmed: 17854007
Cell Mol Gastroenterol Hepatol. 2022;13(4):1161-1179
pubmed: 34990887
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):2-3
pubmed: 31648974
Int J Mol Sci. 2021 Jul 16;22(14):
pubmed: 34299236
Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G716-22
pubmed: 21233277
Front Immunol. 2022 Feb 03;13:829525
pubmed: 35185922
J Crohns Colitis. 2020 Feb 10;14(2):240-253
pubmed: 31325355
Inflamm Res. 2013 Dec;62(12):1015-23
pubmed: 24077843
Gastroenterology. 2002 Jun;122(7):1987-2000
pubmed: 12055604
Acta Physiol (Oxf). 2019 Mar;225(3):e13163
pubmed: 29998613
Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17813-8
pubmed: 15601766
Respirology. 2012 Apr;17(3):533-40
pubmed: 22295989
Respir Res. 2012 Jul 31;13:63
pubmed: 22849850
J Crohns Colitis. 2019 Feb 01;13(2):218-229
pubmed: 30295779
Curr Opin Pharmacol. 2012 Dec;12(6):729-35
pubmed: 22832233
Mol Metab. 2020 Sep;39:100983
pubmed: 32229247
J Clin Invest. 2009 Jun;119(6):1626-37
pubmed: 19436111
J Clin Invest. 2011 Feb;121(2):658-70
pubmed: 21266776
Free Radic Biol Med. 2009 Dec 15;47(12):1731-41
pubmed: 19778604
Gene Expr. 2018 May 18;18(2):71-87
pubmed: 29325602
Nature. 2022 Mar;603(7903):907-912
pubmed: 35296854
Int J Mol Sci. 2021 Jun 10;22(12):
pubmed: 34200555
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12163-8
pubmed: 25092323
Nat Immunol. 2014 Jul;15(7):676-86
pubmed: 24908389
Front Immunol. 2022 Jan 26;13:815775
pubmed: 35154132
J Immunol. 2001 Sep 1;167(5):2651-6
pubmed: 11509607
Science. 2014 Aug 8;345(6197):679-84
pubmed: 25104388
Mucosal Immunol. 2014 Nov;7(6):1467-79
pubmed: 24850427
Front Immunol. 2021 Jun 08;12:636954
pubmed: 34168641
Nat Rev Endocrinol. 2017 Dec;13(12):710-730
pubmed: 28849786
Br J Pharmacol. 2021 Aug;178(16):3140-3156
pubmed: 33145756
Cells. 2022 Apr 07;11(8):
pubmed: 35455931
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584
pubmed: 28743984
Nature. 2019 Dec;576(7785):143-148
pubmed: 31776512
Cell Biol Int. 2022 Jan;46(1):46-51
pubmed: 34658125
EMBO J. 2017 Jan 4;36(1):102-115
pubmed: 27827809
Int J Mol Sci. 2023 Jan 12;24(2):
pubmed: 36675038
Eur Respir J. 2023 Mar 9;61(3):
pubmed: 36396144
Eur J Immunol. 2003 Apr;33(4):1073-83
pubmed: 12672074
Nat Commun. 2016 Oct 25;7:13129
pubmed: 27779191
J Immunol Res. 2019 Dec 1;2019:7247238
pubmed: 31886308
J Immunol. 2005 Nov 15;175(10):6900-8
pubmed: 16272349
J Crohns Colitis. 2019 Jan 01;13(1):67-78
pubmed: 30496425
J Virol. 2017 Sep 12;91(19):
pubmed: 28724759
J Crohns Colitis. 2019 Sep 19;13(9):1186-1200
pubmed: 31220227
Nat Med. 2003 Feb;9(2):213-9
pubmed: 12524534
Immunity. 2018 Jan 16;48(1):120-132.e8
pubmed: 29343433
N Engl J Med. 2020 Dec 31;383(27):2652-2664
pubmed: 33382932
Nature. 2011 Jul 27;475(7357):519-23
pubmed: 21796211
Nutrients. 2022 Jun 27;14(13):
pubmed: 35807844
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32105-32113
pubmed: 33239446
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Mucosal Immunol. 2019 May;12(3):733-745
pubmed: 30742043
Gastroenterology. 2011 May;140(6):1756-1767
pubmed: 21530742
Nature. 2011 Jul 27;475(7357):524-7
pubmed: 21796212
Circulation. 2023 Jan 31;147(5):388-408
pubmed: 36416142
Cell. 2004 Oct 15;119(2):299-309
pubmed: 15479645
Nat Commun. 2019 Apr 1;10(1):1482
pubmed: 30931941
Inflammation. 2005 Dec;29(4-6):141-6
pubmed: 17086498
Int J Mol Sci. 2019 Sep 12;20(18):
pubmed: 31547302
Structure. 2022 Jul 7;30(7):1016-1024.e5
pubmed: 35537452
Gut. 2009 Aug;58(8):1152-67
pubmed: 19592695
Nat Microbiol. 2020 Jul;5(7):929-942
pubmed: 32284563

Auteurs

Guoqiang Zhong (G)

Inflammatory Bowel Diseases Research Center, Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Chengcheng He (C)

Inflammatory Bowel Diseases Research Center, Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Shanping Wang (S)

Inflammatory Bowel Diseases Research Center, Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Chuangzhen Lin (C)

Inflammatory Bowel Diseases Research Center, Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Mingsong Li (M)

Inflammatory Bowel Diseases Research Center, Department of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH